VATs in lung cancer: Who and How
(胸腔镜的使用策略)
Adjuvant radiotherapy in lung cancer: When, Why and How？
(肺癌辅助放疗的治疗策略)
How to manage mediastinal non-thymoma tumors: The thoracic surgeon's position
(胸外科医生在管理纵隔非胸腺来源的肿瘤的地位和作用)
Lung Cancer: Modern non-invasive staging——guidelines and beyond advanced NSCLC
(肺癌的最新非侵入性分期指南)
Adjuvant and Neoadjuvant chemotherapy in lung cancer: When, Why and How？
(肺癌辅助化疗及新辅助化疗: 何时、为什么、怎么做？)
Early diagnosis of Lung Cancer
(肺癌早期诊断)
Lung Cancer: Diagnostic treatment algorithm in 2011 and the role of molecular testing
(2011年肺癌诊断及分子诊断的地位)
NSCLC: New ultrasound classification system for predicting of malignancy in mediastinal lymph nodes
(非小细胞肺癌中超声分类系统预测纵隔恶性淋巴结的应用)
Ifosfomide in Sarcomas and solid tumors other then SCLC - Baxter Sponsor
The role of Ifosfomide in the treatment of small-cell lung cancer (SCLC) - Chinese Experience - Baxter Sponsor
